UBS Group’s Adtran ADTN Stock Holding History

UBS Group’s Portfolio ADTN Stock Details ADTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-17,980	Closed	-$193K	–	7685
2018 Q4	$193K	Buy	+17,980	New	+$245K	﹤0.01%	4978

Other funds holding ADTN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group's ADTN Position: Q1 2026 in Review

UBS Group increased its Adtran (ADTN) stake by 48% in Q1 2026, buying an estimated $820K and bringing the position to 249,157 shares worth $3.13M. The position accounts for ﹤0.01% of the portfolio, ranked #4554.

UBS Group first reported a position in ADTN in Q4 2014 and has held it in 44 quarters since. 227 funds tracked by Wall St. Rank hold ADTN as of Q1 2026.

UBS Group held 249,157 shares of Adtran worth $3.13M as of Q1 2026.
UBS Group bought 80,945 Adtran shares in Q1 2026, an estimated $820K.
Adtran made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4554 holding.
UBS Group first reported a position in Adtran in Q4 2014 and has held it in 44 quarters since.
227 funds tracked by Wall St. Rank held Adtran as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.